Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population.

Kishikawa T, Maeda Y, Nii T, Motooka D, Matsumoto Y, Matsushita M, Matsuoka H, Yoshimura M, Kawada S, Teshigawara S, Oguro E, Okita Y, Kawamoto K, Higa S, Hirano T, Narazaki M, Ogata A, Saeki Y, Nakamura S, Inohara H, Kumanogoh A, Takeda K, Okada Y.

Ann Rheum Dis. 2020 Jan;79(1):103-111. doi: 10.1136/annrheumdis-2019-215743. Epub 2019 Nov 7.

2.

A novel homoplasmic mitochondrial DNA mutation (m.13376T>C, p.I347T) of MELAS presenting characteristic medial temporal lobe atrophy.

Sasaki R, Ohta Y, Hatanaka N, Tadokoro K, Nomura E, Shang J, Takemoto M, Hishikawa N, Yamashita T, Omote Y, Morimoto E, Teshigawara S, Wada J, Goto YI, Abe K.

J Neurol Sci. 2020 Jan 15;408:116460. doi: 10.1016/j.jns.2019.116460. Epub 2019 Oct 25. No abstract available.

PMID:
31689606
3.

Fatal case of TAFRO syndrome associated with over-immunosuppression: a case report and review of the literature.

Matsuhisa T, Takahashi N, Nakaguro M, Sato M, Inoue E, Teshigawara S, Ozawa Y, Kondo T, Nakamura S, Sato J, Ban N.

Nagoya J Med Sci. 2019 Aug;81(3):519-528. doi: 10.18999/nagjms.81.3.519.

4.

Pathological assessment of the lymph node biopsies for lymphadenopathy in rheumatoid arthritis.

Yamada C, Oguro E, Tsuji S, Kudo-Tanaka E, Teshigawara S, Ohshima S, Hashimoto J, Saeki Y, Horiuchi T, Iizuka N, Tomita Y, Hoshida Y.

Mod Rheumatol. 2019 Oct 17:1-8. doi: 10.1080/14397595.2019.1675260. [Epub ahead of print]

PMID:
31571513
5.

Diffusion Weighted Whole Body Imaging with Background Body Signal Suppression (DWIBS) Was Useful for the Diagnosis and Follow-up of Giant Cell Arteritis.

Matsuoka H, Yoshida Y, Oguro E, Murata A, Kuzuya K, Okita Y, Teshigawara S, Yoshimura M, Isoda K, Harada Y, Kaminou T, Ohshima S, Saeki Y.

Intern Med. 2019 Jul 15;58(14):2095-2099. doi: 10.2169/internalmedicine.2479-18. Epub 2019 Apr 17.

6.

Diffusion-weighted Whole-body Imaging with Background Body Signal Suppression (DWIBS) as a Novel Imaging Modality for Disease Activity Assessment in Takayasu's Arteritis.

Oguro E, Ohshima S, Kikuchi-Taura A, Murata A, Kuzuya K, Okita Y, Matsuoka H, Teshigawara S, Yoshimura M, Yoshida Y, Isoda K, Kudo-Tanaka E, Harada Y, Kaminou T, Saeki Y.

Intern Med. 2019 May 1;58(9):1355-1360. doi: 10.2169/internalmedicine.1792-18. Epub 2019 Jan 10.

7.

Crosstalk between tumor necrosis factor-alpha signaling and aryl hydrocarbon receptor signaling in nuclear factor -kappa B activation: A possible molecular mechanism underlying the reduced efficacy of TNF-inhibitors in rheumatoid arthritis by smoking.

Nii T, Kuzuya K, Kabata D, Matsui T, Murata A, Ohya T, Matsuoka H, Shimizu T, Oguro E, Okita Y, Udagawa C, Yoshimura M, Kudo-Tanaka E, Teshigawara S, Harada Y, Yoshida Y, Isoda K, Tsuji SI, Ohshima S, Hashimoto J, Shintani A, Takehana Y, Tohma S, Saeki Y.

J Autoimmun. 2019 Mar;98:95-102. doi: 10.1016/j.jaut.2018.12.004. Epub 2018 Dec 25.

PMID:
30591403
8.

Identification of Novel Urinary Biomarkers for Predicting Renal Prognosis in Patients With Type 2 Diabetes by Glycan Profiling in a Multicenter Prospective Cohort Study: U-CARE Study 1.

Mise K, Imamura M, Yamaguchi S, Teshigawara S, Tone A, Uchida HA, Eguchi J, Nakatsuka A, Ogawa D, Yoshida M, Yamada M, Shikata K, Wada J.

Diabetes Care. 2018 Aug;41(8):1765-1775. doi: 10.2337/dc18-0030. Epub 2018 Jun 21.

PMID:
29930140
9.

Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus Model.

Zeggar S, Watanabe KS, Teshigawara S, Hiramatsu S, Katsuyama T, Katsuyama E, Watanabe H, Matsumoto Y, Kawabata T, Sada KE, Niki T, Hirashima M, Wada J.

Arthritis Rheumatol. 2018 Jul;70(7):1089-1101. doi: 10.1002/art.40467. Epub 2018 May 24.

10.

Sporotrichal Tenosynovitis Diagnosed Helpfully by Musculoskeletal Ultrasonography.

Shimizu T, Akita S, Harada Y, Oguro E, Okita Y, Shigesaka M, Matsuoka H, Nii T, Teshigawara S, Kudo-Tanaka E, Tsuji S, Matsushita M, Ohshima S, Hoshida Y, Hashimoto J, Saeki Y.

Intern Med. 2017;56(10):1243-1246. doi: 10.2169/internalmedicine.56.7912. Epub 2017 May 15.

11.

Phosphorylated signal transducer and activator of transcription 3 in the epidermis in adult-onset Still's disease.

Takeichi T, Watanabe N, Muro Y, Teshigawara S, Sato M, Ban N, Akiyama M.

J Dermatol. 2017 Oct;44(10):1172-1175. doi: 10.1111/1346-8138.13888. Epub 2017 May 4.

PMID:
28470759
12.

Elevated soluble CD14-subtype (PRESEPSIN; P-SEP) levels in rheumatoid arthritis (RA) patients with bacterial infection.

Tsuji S, Kitatoube A, Kikuchi-Taura A, Oguro E, Shigesaka M, Okita Y, Shimizu T, Nii T, Teshigawara S, Tanaka E, Harada Y, Matsushita M, Hashimoto J, Ohshima S, Takahashi G, Endo S, Saeki Y.

Mod Rheumatol. 2017 Jul;27(4):718-720. doi: 10.1080/14397595.2016.1246119. Epub 2016 Oct 27. No abstract available.

PMID:
27785932
13.

Hemophagocytic lymphohistiocytosis with leukoencephalopathy in a patient with dermatomyositis accompanied with peripheral T-cell lymphoma: a case report.

Teshigawara S, Katada Y, Maeda Y, Yoshimura M, Kudo-Tanaka E, Tsuji S, Harada Y, Matsushita M, Ohshima S, Watanabe K, Kumode T, Hoshida Y, Saeki Y.

J Med Case Rep. 2016 Aug 2;10:212. doi: 10.1186/s13256-016-0986-4.

14.

Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis.

Nakatsuka A, Matsuyama M, Yamaguchi S, Katayama A, Eguchi J, Murakami K, Teshigawara S, Ogawa D, Wada N, Yasunaka T, Ikeda F, Takaki A, Watanabe E, Wada J.

Sci Rep. 2016 Feb 17;6:21721. doi: 10.1038/srep21721.

15.

Beneficial impact of Gpnmb and its significance as a biomarker in nonalcoholic steatohepatitis.

Katayama A, Nakatsuka A, Eguchi J, Murakami K, Teshigawara S, Kanzaki M, Nunoue T, Hida K, Wada N, Yasunaka T, Ikeda F, Takaki A, Yamamoto K, Kiyonari H, Makino H, Wada J.

Sci Rep. 2015 Nov 19;5:16920. doi: 10.1038/srep16920.

16.

Monocyte CD64 expression as a novel biomarker for the disease activity of systemic lupus erythematosus.

Kikuchi-Taura A, Yura A, Tsuji S, Ohshima S, Kitatoube A, Shimizu T, Nii T, Katayama M, Teshigawara S, Yoshimura M, Kudo-Tanaka E, Harada Y, Matsushita M, Hashimoto J, Saeki Y.

Lupus. 2015 Sep;24(10):1076-80. doi: 10.1177/0961203315579093. Epub 2015 Mar 24.

PMID:
25804673
17.

Early therapeutic intervention with methotrexate prevents the development of rheumatoid arthritis in patients with recent-onset undifferentiated arthritis: A prospective cohort study.

Kudo-Tanaka E, Shimizu T, Nii T, Teshigawara S, Yoshimura M, Watanabe A, Tsuji S, Tsuboi H, Hirao M, Yura A, Harada Y, Sueishi M, Suenaga Y, Chiba N, Tonai T, Saisho K, Ogata A, Matsushita M, Hashimoto J, Ohshima S, Tohma S, Saeki Y.

Mod Rheumatol. 2015;25(6):831-6. doi: 10.3109/14397595.2015.1031364. Epub 2015 Apr 30.

PMID:
25800638
18.

Translocase of inner mitochondrial membrane 44 alters the mitochondrial fusion and fission dynamics and protects from type 2 diabetes.

Wang Y, Katayama A, Terami T, Han X, Nunoue T, Zhang D, Teshigawara S, Eguchi J, Nakatsuka A, Murakami K, Ogawa D, Furuta Y, Makino H, Wada J.

Metabolism. 2015 Jun;64(6):677-88. doi: 10.1016/j.metabol.2015.02.004. Epub 2015 Feb 23.

PMID:
25749183
19.

Identification of circulating miR-101, miR-375 and miR-802 as biomarkers for type 2 diabetes.

Higuchi C, Nakatsuka A, Eguchi J, Teshigawara S, Kanzaki M, Katayama A, Yamaguchi S, Takahashi N, Murakami K, Ogawa D, Sasaki S, Makino H, Wada J.

Metabolism. 2015 Apr;64(4):489-97. doi: 10.1016/j.metabol.2014.12.003. Epub 2014 Dec 18.

PMID:
25726255
20.

Pemt deficiency ameliorates endoplasmic reticulum stress in diabetic nephropathy.

Watanabe M, Nakatsuka A, Murakami K, Inoue K, Terami T, Higuchi C, Katayama A, Teshigawara S, Eguchi J, Ogawa D, Watanabe E, Wada J, Makino H.

PLoS One. 2014 Mar 25;9(3):e92647. doi: 10.1371/journal.pone.0092647. eCollection 2014.

21.

Serum vaspin levels are associated with physical activity or physical fitness in Japanese: a pilot study.

Miyatake N, Wada J, Nakatsuka A, Sakano N, Teshigawara S, Miyachi M, Tabata I, Numata T.

Environ Health Prev Med. 2014 May;19(3):200-6. doi: 10.1007/s12199-013-0375-1. Epub 2014 Jan 4.

22.

Urinary angiotensinogen is a marker for tubular injuries in patients with type 2 diabetes.

Terami T, Wada J, Inoue K, Nakatsuka A, Ogawa D, Teshigawara S, Murakami K, Katayama A, Eguchi J, Makino H.

Int J Nephrol Renovasc Dis. 2013 Oct 22;6:233-40. doi: 10.2147/IJNRD.S51829. eCollection 2013.

23.

Urinary fetuin-A is a novel marker for diabetic nephropathy in type 2 diabetes identified by lectin microarray.

Inoue K, Wada J, Eguchi J, Nakatsuka A, Teshigawara S, Murakami K, Ogawa D, Terami T, Katayama A, Tone A, Iseda I, Hida K, Yamada M, Ogawa T, Makino H.

PLoS One. 2013 Oct 15;8(10):e77118. doi: 10.1371/journal.pone.0077118. eCollection 2013.

24.

Serum galectin-9 levels are elevated in the patients with type 2 diabetes and chronic kidney disease.

Kurose Y, Wada J, Kanzaki M, Teshigawara S, Nakatsuka A, Murakami K, Inoue K, Terami T, Katayama A, Watanabe M, Higuchi C, Eguchi J, Miyatake N, Makino H.

BMC Nephrol. 2013 Jan 22;14:23. doi: 10.1186/1471-2369-14-23.

25.

Visceral adipose tissue-derived serine proteinase inhibitor inhibits apoptosis of endothelial cells as a ligand for the cell-surface GRP78/voltage-dependent anion channel complex.

Nakatsuka A, Wada J, Iseda I, Teshigawara S, Higashio K, Murakami K, Kanzaki M, Inoue K, Terami T, Katayama A, Hida K, Eguchi J, Ogawa D, Matsuki Y, Hiramatsu R, Yagita H, Kakuta S, Iwakura Y, Makino H.

Circ Res. 2013 Mar 1;112(5):771-80. doi: 10.1161/CIRCRESAHA.111.300049. Epub 2013 Jan 10. Erratum in: Circ Res. 2013 Apr 26;112(9):e98.

PMID:
23307819
26.

The serum vaspin levels are reduced in Japanese chronic hemodialysis patients.

Inoue J, Wada J, Teshigawara S, Hida K, Nakatsuka A, Takatori Y, Kojo S, Akagi S, Nakao K, Miyatake N, McDonald JF, Makino H.

BMC Nephrol. 2012 Dec 3;13:163. doi: 10.1186/1471-2369-13-163.

27.

Activation of liver X receptor inhibits osteopontin and ameliorates diabetic nephropathy.

Tachibana H, Ogawa D, Matsushita Y, Bruemmer D, Wada J, Teshigawara S, Eguchi J, Sato-Horiguchi C, Uchida HA, Shikata K, Makino H.

J Am Soc Nephrol. 2012 Nov;23(11):1835-46. doi: 10.1681/ASN.2012010022. Epub 2012 Oct 18.

28.

Vaspin is an adipokine ameliorating ER stress in obesity as a ligand for cell-surface GRP78/MTJ-1 complex.

Nakatsuka A, Wada J, Iseda I, Teshigawara S, Higashio K, Murakami K, Kanzaki M, Inoue K, Terami T, Katayama A, Hida K, Eguchi J, Horiguchi CS, Ogawa D, Matsuki Y, Hiramatsu R, Yagita H, Kakuta S, Iwakura Y, Makino H.

Diabetes. 2012 Nov;61(11):2823-32. doi: 10.2337/db12-0232. Epub 2012 Jul 26.

29.

Serum vaspin concentrations are closely related to insulin resistance, and rs77060950 at SERPINA12 genetically defines distinct group with higher serum levels in Japanese population.

Teshigawara S, Wada J, Hida K, Nakatsuka A, Eguchi J, Murakami K, Kanzaki M, Inoue K, Terami T, Katayama A, Iseda I, Matsushita Y, Miyatake N, McDonald JF, Hotta K, Makino H.

J Clin Endocrinol Metab. 2012 Jul;97(7):E1202-7. doi: 10.1210/jc.2011-3297. Epub 2012 Apr 26.

PMID:
22539588
30.

A case of type 2 diabetes and metastatic liver cancer exhibiting hypercholesterolemia with abnormal lipoproteins.

Kanzaki M, Wada J, Nakatsuka A, Teshigawara S, Murakami K, Inoue K, Terami T, Katayama A, Nasu J, Yamamoto K, Makino H.

Intern Med. 2012;51(6):619-23. Epub 2012 Mar 15.

31.

Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes.

Kanzaki M, Wada J, Sugiyama K, Nakatsuka A, Teshigawara S, Murakami K, Inoue K, Terami T, Katayama A, Eguchi J, Akiba H, Yagita H, Makino H.

Endocrinology. 2012 Feb;153(2):612-20. doi: 10.1210/en.2011-1579. Epub 2011 Dec 20.

PMID:
22186414
32.

Impact of circulating vaspin levels on metabolic variables in elderly twins.

Hida K, Poulsen P, Teshigawara S, Nilsson E, Friedrichsen M, Ribel-Madsen R, Grunnet L, Lund SS, Wada J, Vaag A.

Diabetologia. 2012 Feb;55(2):530-2. doi: 10.1007/s00125-011-2385-0. Epub 2011 Nov 25. No abstract available.

PMID:
22116078
33.

RXR antagonism induces G0 /G1 cell cycle arrest and ameliorates obesity by up-regulating the p53-p21(Cip1) pathway in adipocytes.

Nakatsuka A, Wada J, Hida K, Hida A, Eguchi J, Teshigawara S, Murakami K, Kanzaki M, Inoue K, Terami T, Katayama A, Ogawa D, Kagechika H, Makino H.

J Pathol. 2012 Apr;226(5):784-95. doi: 10.1002/path.3001. Epub 2012 Feb 9.

PMID:
21956786
34.

Two novel mutations of lecithin:cholesterol acyltransferase (LCAT) gene and the influence of APOE genotypes on clinical manifestations.

Katayama A, Wada J, Kataoka HU, Yamasaki H, Teshigawara S, Terami T, Inoue K, Kanzaki M, Murakami K, Nakatsuka A, Sugiyama H, Koide N, Bujo H, Makino H.

NDT Plus. 2011 Oct;4(5):299-302. doi: 10.1093/ndtplus/sfr091. Epub 2011 Jul 26.

35.

[Chemerin, RBP4 and vaspin].

Wada J, Teshigawara S, Nakatsuka A.

Nihon Rinsho. 2011 Jan;69 Suppl 1:231-6. Review. Japanese. No abstract available.

PMID:
21766603
36.

[Obesity: Progress in diagnosis and treatment; Topics, IV. Recent topics: 3. Obesity and new secretory factors; 1) Vaspin].

Wada J, Teshigawara S, Nakatsuka A, Makino H.

Nihon Naika Gakkai Zasshi. 2011 Apr 10;100(4):996-1001. Japanese. No abstract available.

PMID:
21626837
37.

Collectrin is involved in the development of salt-sensitive hypertension by facilitating the membrane trafficking of apical membrane proteins via interaction with soluble N-ethylmaleiamide-sensitive factor attachment protein receptor complex.

Yasuhara A, Wada J, Malakauskas SM, Zhang Y, Eguchi J, Nakatsuka A, Murakami K, Kanzaki M, Teshigawara S, Yamagata K, Le TH, Makino H.

Circulation. 2008 Nov 18;118(21):2146-55. doi: 10.1161/CIRCULATIONAHA.108.787259. Epub 2008 Nov 3. Erratum in: Circulation. 2014 Feb 4;129(5):e325. Circulation. 2015 Jul 7;132(1):e13.

PMID:
18981302
38.

[Hypolipidemia of renal diseases].

Teshigawara S, Wada J, Makino H.

Nihon Rinsho. 2007 Jul 28;65 Suppl 7:645-8. Review. Japanese. No abstract available.

PMID:
17824103
39.

Bilateral ureteral stenosis and duodenal perforation in a patient with dermatomyositis.

Morita Y, Sakuta T, Nagasu H, Kuwabara A, Tokuoka Y, Teshigawara S, Horike H, Kashihara N.

Mod Rheumatol. 2007;17(1):54-6. Epub 2007 Feb 20.

PMID:
17278023
40.

Dynamics of concentration fluctuations along the coexistence curve of a binary mixture.

Hamano K, Teshigawara S, Koyama T, Kuwahara N.

Phys Rev A Gen Phys. 1986 Jan;33(1):485-489. No abstract available.

PMID:
9896634
41.

Effects of dl-alpha-tocopheryl nicotinate on coronary circulation and development of coronary collateral vessels.

Yasue T, Kato T, Teshigawara S, Kobayashi H, Shoji Y, Hayase S, Ojima A, Sugiyama K, Sagami F.

Jpn Circ J. 1977 Oct;41(10):1073-83. No abstract available.

PMID:
592470
42.

[Autopsy study of metastatic primary liposarcoma of the left popliteal region with various neurologic symptoms].

Kobayashi H, Yasue T, Hayase S, Teshigawara S, Ikeda T.

Rinsho Shinkeigaku. 1975 Oct;15(10):713-9. Japanese. No abstract available.

PMID:
177240
43.

[Atherosclerotic indices of aortic and coronary arteries in the middle part of Japan (Gifu) (author's transl)].

Kato T, Yasue T, Teshigawara S.

Jpn Circ J. 1974 Nov;38(11):1013-15, 1017-31. Japanese. No abstract available.

PMID:
4436933

Supplemental Content

Loading ...
Support Center